US Broker Ratings

Genmab A/S (GMAB) Stock Analysis: Investors Eye an 18% Upside in Biotechnology Powerhouse

Genmab A/S (GMAB), a prominent player in the biotechnology industry, is capturing investor attention with its impressive financial metrics and robust growth potential. Headquartered in Copenhagen, Denmark, Genmab specializes in..

Waystar Holding Corp. (WAY) Stock Analysis: A Compelling 39.5% Upside Potential for Investors

In the dynamic realm of healthcare technology, Waystar Holding Corp. (NASDAQ: WAY) stands out with its innovative cloud-based solutions for healthcare payments. As the company continues to bolster its presence..

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Analyst Ratings and Potential 8% Upside

Tenet Healthcare Corporation (NYSE: THC) stands as a notable player in the healthcare sector, operating within the medical care facilities industry. Headquartered in Dallas, Texas, and with a market capitalization..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A Promising Upside with 24% Potential Growth

Neurocrine Biosciences, Inc. (NBIX), a key player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, has been attracting significant attention from investors. With a market..

Alcon Inc. (ALC) Investor Outlook: Eyeing a 35% Upside with Strong Buy Ratings

Alcon Inc. (NYSE: ALC), a Swiss titan in the healthcare sector, is drawing significant attention from investors as it navigates the competitive landscape of the medical instruments and supplies industry...

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 89.6% Revenue Surge Amidst Strategic Collaborations

Tempus AI, Inc. (NASDAQ: TEM), a leading player in the healthcare technology sector, presents a unique investment narrative marked by impressive revenue growth and strategic industry partnerships, but also fraught..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 51% Potential Upside Amidst Clinical Advancements

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotech sector, has become a focal point for investors due to its compelling pipeline and a notable potential upside. The..

Pfizer, Inc. (PFE) Stock Analysis: Exploring the 16% Upside Potential and Robust Dividend Yield

Pfizer Inc. (PFE), a titan in the healthcare sector, continues to be a focal point for investors, offering a blend of steady dividends and potential upside. With a market capitalization..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Unveiling Growth Potential with a 2.65% Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent name in the healthcare sector, continues to capture investor attention with its comprehensive range of offerings in the specialty and generic drug..

Centene Corporation (CNC) Stock Analysis: Evaluating its Position Amidst Healthcare Sector Dynamics

Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans industry, is navigating a complex landscape of opportunities and challenges. With a market capitalization of $17.56 billion, Centene is..

The Ensign Group, Inc. (ENSG) Stock Analysis: Navigating a 2.89% Upside in Healthcare Growth

The Ensign Group, Inc. (NASDAQ: ENSG) is capturing investor attention with its solid position within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of..

Elevance Health, Inc. (ELV) Stock Analysis: A Promising Healthcare Play with a 6.4% Upside Potential

Elevance Health, Inc. (NYSE: ELV), a prominent player in the U.S. healthcare sector, is drawing attention from investors due to its robust market positioning and potential for further growth. With..

Royalty Pharma plc (RPRX) Stock Analysis: Unveiling a 23.59% Upside Potential in the Biotech Royalty Space

Royalty Pharma plc (NASDAQ: RPRX) stands out as a unique player in the biopharmaceutical industry, carving a niche as both a buyer of biopharmaceutical royalties and a catalyst for innovation...

Encompass Health Corporation (EHC) Stock Analysis: A Promising 13% Upside Potential for Investors

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, specializes in providing post-acute healthcare services across the United States and Puerto Rico. With a market capitalization of..

BeOne Medicines Ltd. (ONC) Stock Analysis: Exploring a 19% Potential Upside in the Biotech Sector

BeOne Medicines Ltd. (ONC), a Swiss-based biotechnology firm, has captured investor attention with a promising potential upside of 19.05%, according to analyst ratings. With a market capitalization of $37.79 billion..

CVS Health Corporation (CVS) Stock Analysis: Navigating Healthcare Growth with a 7.56% Upside Potential

CVS Health Corporation (NYSE: CVS) stands as a titan in the healthcare sector, offering comprehensive health solutions through its diverse operational segments: Health Care Benefits, Health Services, and Pharmacy &..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating a 20% Potential Upside Amidst a Robust Dividend Yield

For investors eyeing opportunities in the healthcare sector, Bristol-Myers Squibb Company (NYSE: BMY) presents an intriguing proposition. With a market capitalization of $89.48 billion, this pharmaceutical giant is a key..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating the Healthcare Sector with a 10.65% Upside Potential

Fresenius Medical Care AG (NYSE: FMS), a global leader in providing dialysis and related services, stands at a pivotal moment for investors. As the world’s largest provider of dialysis products..

Solventum Corporation (SOLV) Stock Analysis: Unpacking a 20.69% Potential Upside in the Healthcare Sector

Solventum Corporation (NYSE: SOLV) is a burgeoning healthcare entity that has been drawing attention with its impressive market presence in the medical instruments and supplies industry. With a market capitalization..

Novo Nordisk A/S (NVO) Stock Analysis: A Healthcare Giant with a Strong Dividend Yield and Significant Upside

Novo Nordisk A/S, a towering presence in the healthcare sector, continues to capture investor attention with its robust dividend yield and potential for significant upside. As a leading player in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds